Nutex Health Inc (NUTX) Quarterly Institutional 13F Update (Q2 2026)

NUTX ranks #3593 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

156 institutions disclose a position in NUTX, but none treat it as a major bet — even Pertento Partners LLP, its most concentrated holder, allocates just 4.2% of its own portfolio to it.

One Plus One Wealth Management, LLC has added to its NUTX position for two straight quarters, increasing it by $4.7M to reach $8.6M today.

NUTX is down 7.3% today, but institutions show net buying of $152.6M this quarter — a divergence between today's price move and the underlying institutional flow.

NUTX posted net income of $179.9M over the trailing twelve months.

• Profitable — net income of $179.9M over the trailing twelve months
• Revenue grew 6.9% year over year
• Net income improved year over year, from $56.3M to $179.9M
• Generated $248.1M in positive operating cash flow
• Current ratio of 3.41x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.17x equity — within a conventional range